A more interesting explanation is that pharma’s presence at the Super Bowl is about more than poor timing or mass market blockbusters. It might represent a sea change in how pharma is presenting ...
Sam Possemiers, CEO of MRM Health, believes that the space is finally coming into maturity. At his own company, that’s in the ...
The uptick in Leqembi (lecanemab) sales comes a few months after the FDA approved a once-weekly subcutaneous injection ...
Bayer is vying to be first to market in the oral Factor XIa category against Bristol Myers Squibb and Johnson & Johnson, ...
Telehealth company GoodRx said it is a "core integration partner" for TrumpRx, providing access to around 30 of Pfizer's ...
Pharma digital success is still largely defined by top level engagement metrics such as page visits, time on page, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results